The global pharmaceutical industry is undergoing a consolidation phase in order to combat price pressure, competition and patent cliffs. Innovation is of vital importance for steady growth of pharmaceutical companies. Pharmaceutical companies have been mainly dependent on a few blockbuster molecules. However,with rapid decline in research and development (R&D) productivity and non-conducive regulatory environment, companies need to find different avenues of growth. The patent expiry of blockbuster drugs is expected to pave way for generics. Due to difference in genetic composition of varied individuals, innovation is becoming more complex.This is influencing players offering complementary products and services to collaborate for new product development.
There are four major factors that are impacting the value creation in pharmaceutical industry:
Demand for personalized medicines is increasing in order to ensure effective treatment of various diseases
Investments in R&D for oncology and NCDs are increasing globally in order to provide cost-effective solutions available to ailing patients.
The industry is facing certain challenges such as patent cliff, cost pressure and regulatory uncertainties across the globe. This is hindering market growth to a certain extent. Moreover, regulatory authorities are becoming more stringent with the drug approval process. However, with respect to drugs for rare diseases, the FDA has offered a fast-track approval process. Moreover, demand for cost-effective treatment for chronic and non-communicable diseases such as diabetes, hypertension, thyroid disorder, obesity, and cancer is increasing. However, there is a dearth of strong products in the pipeline that offer better treatment option with fewer side effects. The fear of side effects and long-term treatment costs is encouraging patients to shift to alternative therapies.
Market players need to combat these challenges and keep their pace with the industry to sustain their market share. Mergers, acquisitions, and divestitures of products, companies or business division is a rapidly emerging trend in the market to combat prevalent challenges in the market.Companies are more focused in terms of therapy areas and hence, are divesting less focused therapy businesses. A good example is the swap deal between GSK and Novartis in 2015.
Moreover, pharmaceutical companies are investing in consumer health products,with increasing consumer’s health awareness and emerging trend of self-medication. These trends are encouraging pharmaceutical companies to enter the OTC market and leverage their brand equity among the doctors, chemists and consumers. Companies such as GlaxoSmithKline, Cipla, Pfizer, Merck, Sun Pharma, and Abbott have a focused division or subsidiary for consumer healthcare products and markets.
Moreover, to combat increasing cost pressure, companies are evolving their distribution channel. Establishing facilities or presence through collaboration in regional markets has helped companies meet local demand with reduced costs and delivery time. Emergence of e-pharmacy has resulted in creation of a separate team in the organization to service consumers ordering medicines online. Moreover, companies are connecting with consumers through social media, which helps improve brand visibility. The distribution channel has thus evolved significantly from the decade old channel consisting of only wholesalers and physical retail shops.
Patients are increasingly becoming well informed and organized, sometimes demanding for a particular product from prescribers. Therefore, companies need to be more patient-centric in their approach and provide quality care to consumers. Pharmaceutical companies are focusing on established direct to consumer distribution channels and establishing a more strong relationship with them. Moreover, companies are creating a good purchase experience for consumers through different offerings such as post-purchase medical services, engaging the patient through social media and events, and providing regular product alerts and refilling services.
Growth in Emerging Economies
The pharmaceutical industry is rapidly expanding in emerging economies such as Asia Pacific, Africa, and Latin America. These regions possess immense potential for growth of pharmaceutical companies, owing to inadequate access to medicines, growing population and increasing incidence of non-communicable diseases (NCDs). Besides, demand for contract research and manufacturing is also high in these regions. China and India are the largest emerging markets for CRO and CMO. Companies are highly dependent on China for API supply owing to low purchase cost. Overdependence on a single country can pose a challenge for the pharmaceuticals sector in the near future. Therefore, other emerging countries such as India, Brazil and South Africa are encouraging investments in their country. Besides, global companies are establishing their facilities in Asia Pacific, Middle East and Latin America regions to enable close monitoring and servicing of lucrative regional markets.
Pharmaceutical companies need to focus on an integrated, patient-centric, value-driven approach along with technology integration and strategic partnerships in order to capitalize on lucrative growth opportunities in the market. Major global players in the market include Pfizer Inc., Merck & Co., Inc., Bayer AG, GlaxoSmithKline plc., Sanofi, F. Hoffmann-La Roche AG, AstraZeneca plc. and Novartis AG.
There is a paradigm shift in process in the global pharmaceutical industry from product to a ‘Prodice’ (Product and Service) model, to offer affordable, accessible and quality care to patients.
Mesalazine is an aminosalicylate drug used to treat mild to moderate active ulcerative colitis and maintain remission once achieved. Mesalazine is an anti-inflammatory agent, structurally related to salicylates and non-steroidal anti-inflammatory drugs like acetylsali... View more
Live microorganisms called probiotics are meant to improve one's health when ingested or applied topically. They can be found in yogurt and other fermented foods, dietary supplements, and beauty products. Although bacteria and other microorganisms are frequently perce... View more
Infections, allergies, autoimmune diseases, irritation, injuries, or damage to the eyes, eyelids, or surrounding tissues can cause eye inflammation. Depending on the source of the inflammation, different areas of the eye may be impacted. It is possible for eyes to get... View more
Sodium selenite is a common source of selenium in biological research, because selenium is an essential trace element that is normally delivered by serum. Selenium is found in selenoproteins such as glutathione peroxidase and thioredoxin reductase, which contain selen... View more
Omega-3 fatty acid is major component of fat that the body uses for energy and tissue growth. Omega-3 fatty acids are essential fatty acids in human nutrition. They are found in fish oils, certain vegetable oils, and nut oils. Omega-3 fatty acids are important constit... View more
Diabetes can damage nerves throughout the body. Diabetic neuropathy is the most common complication of diabetes mellitus numbness, pain in the hands, legs and feet, weakness of the muscles in the feet and hands, sharp pains, and insensitivity to pain or temperature ch... View more
Sertraline hydrochloride is the hydrochloride salt of sertraline, a synthetic derivative of naphthalenamine with anti-serotoninergic and anti-depressant properties. Sertraline appears to selectively inhibit the neuronal uptake of serotonin, raising serotonin levels in... View more
The global cattle healthcare market was valued at US$ 7,882.4 Mn in 2021 and is forecast to reach a value of US$ 12,041.3 Mn by 2028 at a CAGR of 6.2% between ... View more
The global preventive vaccines market was valued at US$ 42,660.2 Mn in 2021 and is forecast to reach a value of US$ 80,215.0 Mn by 2028 at a CAGR of 9.4% betwee... View more
The global cancer therapy market was valued at US$ 171,143.8 Mn in 2021 and is forecast to reach a value of US$ 300,830.5 Mn by 2028 at a CAGR of 8.4% between&... View more
Dermatomyositis is an idiopathic inflammatory myopathy characterized by skeletal muscle weakness and skin changes. Dermatomyositis is characterized by a rash accompanying, or more often, preceding muscle weakness. The most common symptom is muscle ... View more
Ependymoma is a type of tumor that can form in the brain or spinal cord. Ependymoma rises from the ependymal cells that line the ventricles of the brain and the center of the spinal cord. Ependymoma can occur at any age, but most often occurs in children under 5... View more
Medical devices are the electronic products which have medical use and make medical claim. The medical devices includes ultrasound products, x-ray machines, medical lasers and neurological interventional kits. Neuro-interventional devices are catheters-based, minimall... View more
Congenital Hyperinsulinism (CHI) is a condition that causes abnormal high level of insulin in an individual, insulin is the hormone that controls blood sugar level. There are different subdivisions of congenital hyperinsulinism which includes Diffuse KATP HI, exercise... View more
Preclinical assets is a fully integrated CRO (Clinical Research Organization) providing services to support drug discovery programs from target discovery through IND (Investigational New Drug) filing and managing Phase I-IV clinical trials. Preclinical resources, serv... View more
The global antibiotics market was valued at US$ 49,081.2 Mn in 2021 and is forecast to reach a value of US$ 67,874.0 Mn by 2028 at a CAGR of 4.7%&nb... View more
The global human insulin drug market was valued at US$ 42,283.9 Mn in 2021 and is forecast to reach a value of US$ 73,127.2 Mn by 2028 a... View more
The global dental caries treatment market was valued at US$ 6,302.2 Mn in 2021 and is forecast to reach a value of US$ 8,691.8 Mn by 2028 at a CAGR of 4.8% between&n... View more